InvestorsHub Logo
Followers 84
Posts 12534
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Tuesday, 05/29/2018 11:51:04 AM

Tuesday, May 29, 2018 11:51:04 AM

Post# of 8413
I might add:
FDA declines to approve Evolus' rival treatment to Botox

U.S. health regulators on Wednesday declined to approve Evolus' rival product to Allergan Plc's Botox, citing certain deficiencies related to its potential treatment for frown lines.

Read more: https://www.cnbc.com/2018/05/16/fda-declines-to-approve-evolus-rival-treatment-to-botox.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News